Office of National Drug Control Policy

Federal RegisterMar 5, 1996

Ask Donna

What actually matters in this document.

Text

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy

AGENCY: Executive Office of the President, Office of National Drug

Control Policy.

ACTION: The Drug Control Research, Data, and Evaluation Committee

(DCRDEC); Notice of establishment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the

Director of the Office of National Drug Control Policy has established

the Drug Control Research, Data, and Evaluation Committee (DCRDEC).

The Committee shall provide an avenue of communications by which a

distinguished expert group representing scientific, engineering, law

enforcement, treatment, and associated international scientific

communities may advise the Director of the Office of National Drug

Control Policy (ONDCP) on questions related to national drug control

research. In pursuing this objective, the DCRDEC may operate in

subgroups composed of selected committee members to conduct detailed

examinations of specific issues related to national drug control policy

research.

The Committee will identify gaps in current data collection to

improve the generation of accurate and useful information on which to

base national drug control policy. It will function solely as an

advisory body and in compliance with the provisions of the Federal

Advisory Committee Act. Its charter will be filed under the Act fifteen

(15) days from the date of this publication.

The Committee will be comprised of approximately fourteen members.

The full DCRDEC subgroup will meet approximately twice per year in

plenary sessions at the convenience of the Director of the ONDCP. In

addition, various sub-committees meet periodically throughout the year.

FOR FURTHER INFORMATION CONTACT: Comments and questions regarding the

Drug Control Research, Data, and Evaluation Committee (DCRDEC) should

be directed to Mr. Edward H. Jurith, General Counsel, Office of

National Drug Control Policy, Executive Office of the President, 750

17th Street, N.W., Washington, D.C. 20500, (202) 395-6709.

Signed at Washington, DC, this 26th day of February, 1996.

Edward H. Jurith,

General Counsel.

[FR Doc. 96-5021 Filed 3-4-96; 8:45 am]

BILLING CODE 3180-02-P

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.